Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs

Go back to Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs
(NASDAQ: ASMB) Delayed: 24.57 +0.08 (0.33%)
Previous Close $24.49    52 Week High $14.50 
Open $24.60    52 Week Low $4.33 
Day High $24.65    P/E N/A 
Day Low $24.00    EPS $0.00 
Volume 181,037